An Guo Huang
Director/Board Member bei Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Profil
An Guo Huang is currently a Director at Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Previously, he worked as the Chief Financial Officer & Board Secretary at Sinocare, Inc. from 2013 to 2023.
Mr. Huang has an undergraduate degree from Hunan Normal University, a graduate degree from Hunan University, and an MBA from Central South University.
Aktive Positionen von An Guo Huang
| Unternehmen | Position | Beginn |
|---|---|---|
Shenzhen Xinnuo Health Industry Investment Co., Ltd.
 Shenzhen Xinnuo Health Industry Investment Co., Ltd. Financial ConglomeratesFinance Shenzhen Xinnuo Health Industry Investment Co. Ltd. engages in the provision of investment services with interests in medical and health industries. Its business activities include investment in biotechnology, biotechnology research and development, health management and consulting, and investment management and advisory services. The company was founded on April 27, 2015 and is headquartered in Shenzhen, China. | Director/Board Member | - |
Ehemalige bekannte Positionen von An Guo Huang
| Unternehmen | Position | Ende |
|---|---|---|
| SINOCARE INC. | Director of Finance/CFO | 29.12.2023 |
Ausbildung von An Guo Huang
| Hunan Normal University | Undergraduate Degree |
| Hunan University | Graduate Degree |
| Central South University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SINOCARE INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shenzhen Xinnuo Health Industry Investment Co., Ltd.
Shenzhen Xinnuo Health Industry Investment Co., Ltd. Financial ConglomeratesFinance Shenzhen Xinnuo Health Industry Investment Co. Ltd. engages in the provision of investment services with interests in medical and health industries. Its business activities include investment in biotechnology, biotechnology research and development, health management and consulting, and investment management and advisory services. The company was founded on April 27, 2015 and is headquartered in Shenzhen, China. | Finance |
